Mark Dixon
Impact in
- Periodontics top 1%
- Oral microbiology and periodontitis research
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
Papers in
- Genetics 11
- Chronic Lymphocytic Leukemia Research 11
-
- Oral microbiology and periodontitis research 6
- Oral Health Pathology and Treatment 3
- Co-authors
- Derry C. Roopenian (6 shared papers)Pamela J. Baker (3 shared papers)Richard T. Evans (3 shared papers)Ellis Johnson (1 shared paper)Peter Baker (3 shared papers)Michael J. Hallek (4 shared papers)Franck Morschhauser (3 shared papers)Günter Fingerle‐Rowson (4 shared papers)
- Journals
- Blood (9 papers)Infection and Immunity (3 papers)Blood Advances (1 paper)Leukemia (1 paper)Journal of Biopharmaceutical Statistics (1 paper)
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
Mark Dixon
23 papers receiving 1.7k citations
Mark Dixon's Hit Papers
Peers
Comparison fields: 5 of 77
- Periodontics 375
- Genetics 788
- Pathology and Forensic Medicine 583
- Immunology 492
- Hematology 202
Countries citing papers authored by Mark Dixon
This map shows the geographic impact of Mark Dixon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Dixon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Dixon more than expected).
Fields of papers citing papers by Mark Dixon
This network shows the impact of papers produced by Mark Dixon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Dixon. The network helps show where Mark Dixon may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Dixon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions Hit paper breakdown → | 2019 | 653 |
| 2 | 1999 | 289 | |
| 3 | 2000 | 140 | |
| 4 | 2017 | 103 | |
| 5 | 2017 | 101 | |
| 6 | 2015 | 77 | |
| 7 | 2000 | 70 | |
| 8 | 2020 | 48 | |
| 9 | 1998 | 44 | |
| 10 | 2000 | 36 | |
| 11 | 1999 | 30 | |
| 12 | 2016 | 24 | |
| 13 | 2015 | 23 | |
| 14 | 2024 | 16 | |
| 15 | 2015 | 12 | |
| 16 | 2014 | 10 | |
| 17 | 2014 | 9 | |
| 18 | 2016 | 9 | |
| 19 | 2022 | 5 | |
| 20 | 2023 | 2 |
About Mark Dixon
Mark Dixon is a scholar working on Genetics, Periodontics, Pathology and Forensic Medicine, Immunology and Pharmacy, having authored 24 papers that have together received 1.7k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (11 papers), Lymphoma Diagnosis and Treatment (8 papers), Oral microbiology and periodontitis research (6 papers), Immunodeficiency and Autoimmune Disorders (5 papers), Oral and gingival health research (4 papers), CAR-T cell therapy research (3 papers), Oral Health Pathology and Treatment (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Periodontics (375 citations), Genetics (788 citations), Pathology and Forensic Medicine (583 citations), Immunology (492 citations) and Hematology (202 citations). Mark Dixon has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Derry C. Roopenian, Pamela J. Baker, Richard T. Evans, Ellis Johnson, Peter Baker, Michael J. Hallek, Franck Morschhauser, Günter Fingerle‐Rowson, Richard C. Houghton and John G. Gribben. Their work appears in journals such as Blood, Infection and Immunity, Blood Advances, Leukemia and Journal of Biopharmaceutical Statistics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.